Donald Trump, HHS, Ashby discussed on POLITICO's Pulse Check


Top priority in HHS is certainly feeling pressure to show that they're making progress. It's hard to think of President Trump being fixated. I've never heard him be fixated on shoe before and bring it up over in this states back to even before as our was confirmed as even before you know, in those meetings, he would say, you know, I, I think you're great. These the issues we're talking about and it would always go back to, well, what can we do on pricing and how fast I, I went back and watched the swearing in it came up than than to that was one of the first things Trump said beyond the policies as are also has continued to remake the personnel had success. Sure. And there are a couple kind of overarching ideas that he's he's had in putting people. Onto place. One is you want private sector people. He doesn't want people from the hill. He wants people who have experienced in a real world who have the knowledge in the context to when they come into the agency. Really the way he puts his know where the money is to really be able to go after the parts of the industries that that can change in that can you know, kind of effect, structural change. And I think by and large, he's got everybody in place on, you know, on top upper levels, but there's still parts of the agencies where there are a lot of holes and you wrote you wrote a story about essentially HHS policy shop, and it's been a little chaotic in part because they don't have a permanent leader. And in fact that permanently I remember has been out there for, you know, waiting on his confirmation for more than a year. At this point you're you're talking about Ashby. The story that I had this week. So Abby, the assistant secretary for planning and evaluation. That's the brain Bank for itchy Chester. One hundred twenty people in this shop. When Alex azar says, I want to do something big on drug pricing. There are teams in Ashby who then try and substantiate that and come up with the policies that as our could then roll out and their other teams around the agency to, but Ashby's sort of the central brain nervous system for HHS what my story got into with some of the political meddling in Ashby over the past year where Trump. Administration politically appointed. People were either killing reports that were critical of of Trump priorities, like allowing refugees to come in to shifting the findings to make them more palatable to the Trump administration's goals like rolling back the now. Every Ashby has been politically influenced in some way. Obama has to be was the Jewish W Bush one was, but the bigger question is, has the Trump administration gone farther in shaping the evidence and data coming out of divisions like the policy shelter and this gets out a attention. I think that is going to be something to watch the next six months is you have an HHS with Alex as are very structured, very into planning, very into keeping everybody on message doing things the right way. And then you have a White House that often does not do those things. They have a very different philosophy. That's a lot more chaotic a lot more ad hoc. Yeah, the president wakes up. He says, he says, I want this done. And and everybody else is off just working on that. And so I think the SP SP is great example where there's a tension between doing things right, doing you know the research doing the policy and this urge to show results to get things done no matter what. And that is that tension between, you know, a more traditional HHS leadership and a definitively nontraditional. White House leadership is something that's, that's definitely out there watch and something that we've seen come up at times when HHS pursues one policy that might seem at odds with the White House. You are going down to just to cover the short term plan fallout. So we'll let you get to that. Listeners can find Adam story on association health plans. My story on Espy the policy shop in the.

Coming up next